Business
BullFrog AI to Present at Benzinga All Access Event on Friday, February 17
GAITHERSBURG, MD / ACCESSWIRE / February 15, 2023 / BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a biopharmaceutical
About this update from Bullfrog Ai Holdings, Inc.
[{"type":"text","content":"GAITHERSBURG, MD / ACCESSWIRE / February 15, 2023 / BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (\"Bullfrog AI\" or the \"Company\"), a biopharmaceutical company focused on applying its proprietary Artificial Intelligence/Machine Learning platform to improve drug development and shorten clinical trial timelines, today announced that management will present during Benzinga's All Access investor event taking place Friday, February 17, 2023, at 11:00 a.m. ET.Vin Singh, Founder and CEO of BullFrog AI, is scheduled to host a presentation and Q&A session during the event as follows.Date: Friday, February 17, 2023Time: 11:00 a.m. Eastern timeWebcast: https://www.youtube.com/live/eNobwWD9QZI?feature=shareA live video webcast will be available using the link above - an archived replay will be made available after the live event on the Benzinga YouTube Channel. For more information on Benzinga All Access, please contact your Benzinga representative.About BullFrog AIBullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University, and others, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP™ Artificial Intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may have otherwise not received the therapies they need.For more information visit BullFrogAI atWebsite: www.bullfrogai.comLinkedIn: https://www.linkedin.com/company/bullfrogai/Forward-Looking StatementsThis press release contains forward-looking statements. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and ...